289 related articles for article (PubMed ID: 37178361)
1. Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany.
Ahn N; Wawro N; Baumeister SE; Nolde M; Gerlach R; Tauscher M; Günter A; Güntner F; Rückert-Eheberg IM; Meisinger C; Linseisen J
Drugs Aging; 2023 Jul; 40(7):653-663. PubMed ID: 37178361
[TBL] [Abstract][Full Text] [Related]
2. Emulating a target trial of proton pump inhibitors and dementia risk using claims data.
Ahn N; Nolde M; Günter A; Güntner F; Gerlach R; Tauscher M; Amann U; Linseisen J; Meisinger C; Rückert-Eheberg IM; Baumeister SE
Eur J Neurol; 2022 May; 29(5):1335-1343. PubMed ID: 35170158
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitor therapy and risk of knee replacement surgery: a general population-based cohort study.
Zeng C; Neogi T; Chan AT; Wei J; Misra D; Lu N; Choi HK; Lei G; Zhang Y
Osteoarthritis Cartilage; 2022 Apr; 30(4):559-569. PubMed ID: 35031493
[TBL] [Abstract][Full Text] [Related]
4. Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort.
Yates TA; Tomlinson LA; Bhaskaran K; Langan S; Thomas S; Smeeth L; Douglas IJ
PLoS Med; 2017 Nov; 14(11):e1002457. PubMed ID: 29161254
[TBL] [Abstract][Full Text] [Related]
5. Association Between Proton Pump Inhibitor Use and Risk of Asthma in Children.
Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B
JAMA Pediatr; 2021 Apr; 175(4):394-403. PubMed ID: 33555324
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis.
Assimon MM; Pun PH; Al-Khatib SM; Brookhart MA; Gaynes BN; Winkelmayer WC; Flythe JE
Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):670-679. PubMed ID: 35285107
[TBL] [Abstract][Full Text] [Related]
7. Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia.
Goldstein FC; Steenland K; Zhao L; Wharton W; Levey AI; Hajjar I
J Am Geriatr Soc; 2017 Sep; 65(9):1969-1974. PubMed ID: 28590010
[TBL] [Abstract][Full Text] [Related]
8. Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.
Gomm W; von Holt K; Thomé F; Broich K; Maier W; Fink A; Doblhammer G; Haenisch B
JAMA Neurol; 2016 Apr; 73(4):410-6. PubMed ID: 26882076
[TBL] [Abstract][Full Text] [Related]
9. Cumulative Use of Proton Pump Inhibitors and Risk of Dementia: The Atherosclerosis Risk in Communities Study.
Northuis CA; Bell EJ; Lutsey PL; George KM; Gottesman RF; Mosley TH; Whitsel EA; Lakshminarayan K
Neurology; 2023 Oct; 101(18):e1771-e1778. PubMed ID: 37558503
[TBL] [Abstract][Full Text] [Related]
10. Chronic omeprazole use in the elderly is associated with decreased risk of dementia and cognitive decline.
Weiss A; Gingold-Belfer R; Boltin D; Beloosesky Y; Koren-Morag N; Meyerovitch J; Sharon E; Schmilovitz-Weiss H
Dig Liver Dis; 2022 May; 54(5):622-628. PubMed ID: 34949554
[TBL] [Abstract][Full Text] [Related]
11. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
[TBL] [Abstract][Full Text] [Related]
12. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
Caro JJ; Salas M; Ward A
Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776
[TBL] [Abstract][Full Text] [Related]
13. Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study.
Wang WT; Li CY; Chang YT; Bai YM; Tsai SJ; Chen TJ; Chiou SH; Chen MH
Allergy Asthma Proc; 2023 Sep; 44(5):345-353. PubMed ID: 37641222
[No Abstract] [Full Text] [Related]
14. Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study.
Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
Eur J Intern Med; 2019 Jan; 59():65-69. PubMed ID: 30154038
[TBL] [Abstract][Full Text] [Related]
15. Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.
Leonard CE; Bilker WB; Brensinger CM; Flockhart DA; Freeman CP; Kasner SE; Kimmel SE; Hennessy S
Stroke; 2015 Mar; 46(3):722-31. PubMed ID: 25657176
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors do not increase the risk of dementia: a systematic review and meta-analysis of prospective studies.
Desai M; Nutalapati V; Srinivasan S; Fathallah J; Dasari C; Chandrasekhar VT; Mohammad B; Kohli D; Vaezi M; Katz PO; Sharma P
Dis Esophagus; 2020 Oct; 33(10):. PubMed ID: 32476013
[TBL] [Abstract][Full Text] [Related]
17. Comparison of hepatotoxicity of tegoprazan, a novel potassium-competitive acid blocker, with proton pump inhibitors using real-world data: A nationwide cohort study.
Kim MG; Im YJ; Lee JH; Kim EY; Yeom SW; Kim JS
Front Med (Lausanne); 2022; 9():1076356. PubMed ID: 36714137
[TBL] [Abstract][Full Text] [Related]
18. A multicentre prospective study evaluating the impact of proton-pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations.
Blanco Dorado S; Maroñas Amigo O; Latorre-Pellicer A; Rodríguez Jato MT; López-Vizcaíno A; Gómez Márquez A; Bardán García B; Belles Medall D; Barbeito Castiñeiras G; Pérez Del Molino Bernal ML; Campos-Toimil M; Otero Espinar F; Blanco Hortas A; Zarra Ferro I; Carracedo Á; Lamas MJ; Fernández-Ferreiro A
Br J Clin Pharmacol; 2020 Aug; 86(8):1661-1666. PubMed ID: 32110830
[TBL] [Abstract][Full Text] [Related]
19. Association Between Proton Pump Inhibitor Use and Risk of Fracture in Children.
Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B
JAMA Pediatr; 2020 Jun; 174(6):543-551. PubMed ID: 32176276
[TBL] [Abstract][Full Text] [Related]
20. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.
Hsiao FY; Mullins CD; Wen YW; Huang WF; Chen PF; Tsai YW
Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1043-9. PubMed ID: 21823195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
